Browsing by 저자 : 이재련
전체 결과 30건 중 1-30 번을 표시중입니다.
- 1 Article 2020 Korean guidelines for the management of metastatic prostate cancer 강병욱 ; 강지훈 ; 김달용 ; et al 2021
- 2 Article Cabozantinib real-world effectiveness in the first-through fourth-line settings for the treatment of metastatic renal cell carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium 이재련 ; Aaron Hansen ; Aly-Khan A Lalani ; et al 2021
- 3 Article Cabozantinib real-world effectiveness in the first-through fourth-line settings for the treatment of metastatic renal cell carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium 이재련 ; Aaron Hansen ; Aly-Khan A Lalani ; et al 2021
- 4 Article Clinical Outcomes of Platinum-ineligible Patients with Advanced Urothelial Carcinoma Treated With First-line PD1/L1 Inhibitors 이재련 ; Alexandra Drakaki ; Archana Agarwal ; et al 2021
- 5 Article Comparison of clinical outcomes in patients with localized or locally advanced urothelial carcinoma treated with neoadjuvant chemotherapy involving gemcitabine-cisplatin and high dose-intensity MVAC 김영석 ; 이용준 ; 이재련 ; et al 2021
- 6 Article Concordance between Response Assessment Using Prostate-Specific Membrane Antigen PET and Serum Prostate-Specific Antigen Levels after Systemic Treatment in Patients with Metastatic Castration Resistant Prostate Cancer: A Systematic Review and Meta-Analysis 김용일 ; 류진숙 ; 우승민 ; et al 2021
- 7 Article Deferred Cytoreductive Nephrectomy in Patients with Newly Diagnosed Metastatic Renal Cell Carcinoma Jeffrey Graham ; 이재련 ; Aaron Hansen ; et al 2020
- 8 Article Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial. 이재련 ; Andre P Fay ; Andrea Necchi ; et al 2020
- 9 Article Efficacy of Savolitinib vs Sunitinib in Patients With MET-Driven Papillary Renal Cell Carcinoma The SAVOIR Phase 3 Randomized Clinical Trial 이재련 ; Anders Mellemgaard ; Anne L'Hernault ; et al 2020
- 10 Article Enfortumab vedotin after PD-1 or PD-L1 inhibitors in cisplatin-ineligible patients with advanced urothelial carcinoma (EV-201): a multicentre, single-arm, phase 2 trial 이재련 ; Andrea Necchi ; Arjun V Balar ; et al 2021
- 11 Article Enfortumab Vedotin in Previously Treated Advanced Urothelial Carcinoma 이재련 ; Christof Vulsteke ; Chunzhang Wu ; et al 2021
- 12 Article Evaluating waiting time with real-world health information in a high-volume cancer center 김규표 ; 김정은 ; 김태원 ; et al 2020
- 13 Article Evaluation of Clear Cell, Papillary, and Chromophobe Renal Cell Carcinoma Metastasis Sites and Association With Survival 이재련 ; Aaron Hansen ; Anna Fraccon ; et al 2021
- 14 Article Evaluation of Clear Cell, Papillary, and Chromophobe Renal Cell Carcinoma Metastasis Sites and Association With Survival 이재련 ; Aaron Hansen ; Anna Fraccon ; et al 2021
-
15
dissertation
Exploration of tumor microenvironment using multiplexed immunohistochemistry and its association with response in advanced or metastatic renal cell carcinoma treated with immune checkpoint inhibitors
김좌훈
2022
- 16 Article FGFR1 is associated with c-MYC and proangiogenic molecules in metastatic renal cell carcinoma under anti-angiogenic therapy 고현정 ; 김필종 ; 박지영 ; et al 2020
- 17 Article Gemcitabine plus carboplatin versus gemcitabine plus oxaliplatin in cisplatin-unfit patients with advanced urothelial carcinoma: a randomised phase II study (COACH, KCSG GU10-16) 박인근 ; 김봉석 ; 김희준 ; et al 2020
- 18 Article Genotypic and Phenotypic Characteristics of Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome in Korean Patients 김미소 ; 김범석 ; 박권오 ; et al 2021
- 19 Article Health-related quality of life in the randomized phase 3 study of ramucirumab plus docetaxel versus placebo plus docetaxel in platinum-refractory advanced urothelial carcinoma (RANGE) 이재련 ; Alexandra Drakaki ; Andrea Necchi ; et al 2020
- 20 Article How Cancer Patients Perceive Clinical Trials (CTs) in the Era of CTs: Current Perception and Its Differences Between Common and Rare Cancers 구하영 ; 김규표 ; 김선영 ; et al 2020
- 21 Article Hyperprogressive Disease in Patients With Urothelial Carcinoma or Renal Cell Carcinoma Treated With PD-1/PD-L1 Inhibitors 이재련 ; 황인환 ; 박인근 ; et al 2020
- 22 Article Open-Label, Single-Arm, Phase II Study of Pembrolizumab Monotherapy as First-Line Therapy in Patients With Advanced Non-Clear Cell Renal Cell Carcinoma 이재련 ; Boris Yakovlevich Alekseev ; Charles Schloss ; et al 2021
- 23 Article Optimal pathological response after neoadjuvant chemotherapy for muscle-invasive bladder cancer: results from a global, multicentre collaboration 이재련 ; Ajjai Alva ; Andrea Gallina ; et al 2021
- 24 Article Radiomics-based prediction model for outcomes of PD-1/PD-L1 immunotherapy in metastatic urothelial carcinoma 김정곤 ; 박계진 ; 박범우 ; et al 2020
- 25 Article Radium-223 in Asian patients with castration-resistant prostate cancer with symptomatic bone metastases: A single-arm phase 3 study 이재련 ; Chung-Hsin Chen ; Daqing Zhou ; et al 2021
- 26 Article Rivaroxaban Versus Low-molecular-weight Heparin for Venous Thromboembolism in Advanced Upper Gastrointestinal Tract and Hepatopancreatobiliary Cancer 김규표 ; 김좌훈 ; 류백렬 ; et al 2020
- 27 Article Synchronous Versus Metachronous Metastatic Disease: Impact of Time to Metastasis on Patient Outcome-Results from the International Metastatic Renal Cell Carcinoma Database Consortium 이재련 ; Anders Overby ; Anna P. Fraccon ; et al 2020
- 28 Article Systemic treatment for advanced urothelial cancer: an update on recent clinical trials and current treatment options 박인근 ; 이재련 2020
- 29 Article Updated efficacy results from the JAVELIN Renal 101 trial: first-line avelumab plus axitinib versus sunitinib in patients with advanced renal cell carcinoma 이재련 ; A. Chudnovsky ; A. di Pietro ; et al 2020
- 30 Article Use of Gemcitabine plus Carboplatin is Associated with Poor Outcomes in Urothelial Carcinoma Patients with Chronic Kidney Disease Stage 4-5 김좌훈 ; 김형돈 ; 박인근 ; et al 2021
1